All In Biotech

Drug Trial Radar · NCT01969643

A Safety Study of SGN-LIV1A in Breast Cancer Patients

A Phase 1, Open-Label, Dose-Escalation Study to Evaluate the Safety and Tolerability of SGN-LIV1A in Patients With Metastatic Breast Cancer

Last checked: Nov 19, 2026Latest source record: Mar 7, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

290

Actual

Start

Oct 22, 2013

Primary completion

Feb 4, 2023

Study completion Feb 4, 2023

Sponsor

Lead sponsor
Seagen Inc.Pfizer (PFE)
Sponsor type
Industry
First posted
Oct 25, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will examine the safety and tolerability of ladiratuzumab vedotin (LV) in patients with metastatic breast cancer. LV will be given alone or in combination with trastuzumab.

Conditions

  • HER2 Positive Breast Neoplasms
  • Hormone Receptor Positive Breast Neoplasms
  • Triple Negative Breast Neoplasms
  • HER2 Mutations Breast Neoplasms

Interventions

  • ladiratuzumab vedotinDrug

    LV will be given into the vein (IV; intravenously)

  • TrastuzumabDrug

    Trastuzumab will be given by IV every 3 weeks at a dose of 6 mg/kg (the first dose will be 8 mg/kg)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of adverse eventsTime frame: Through 1 month following last dose; up to approximately 2 years
  2. Incidence of laboratory abnormalitiesTime frame: Through 1 month following last dose; up to approximately 2 years
  3. Incidence of dose-limiting toxicity (DLT)Time frame: Through 3 weeks after first dose

Locations

38 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Pinnacle Oncology Hematology

    Scottsdale, Arizona

  • UC San Diego / Moores Cancer Center

    La Jolla, California

  • Cedars Sinai Medical Center / Samuel Oschin Comprehensive Cancer Institute

    Los Angeles, California

  • University of California at San Francisco

    San Francisco, California

  • UCLA Medical Center / David Geffen School of Medicine

    Santa Monica, California

  • Rocky Mountain Cancer Centers - Aurora

    Aurora, Colorado

  • Poudre Valley Health System (PVHS)

    Fort Collins, Colorado

  • Yale Cancer Center

    New Haven, Connecticut

  • The Whittingham Cancer Center / Norwalk Hospital

    Norwalk, Connecticut

  • H. Lee Moffitt Cancer Center and Research Institute

    Tampa, Florida

  • Piedmont Cancer Institute

    Atlanta, Georgia

  • University of Chicago Medical Center

    Chicago, Illinois

  • Indiana University Simon Cancer Center

    Indianapolis, Indiana

  • Louisiana State University Health Sciences Center

    New Orleans, Louisiana

  • University of Maryland

    Baltimore, Maryland

  • Dana Farber Cancer Institute

    Boston, Massachusetts

  • Karmanos Cancer Institute / Wayne State University

    Detroit, Michigan

  • Allina Health Cancer Institute

    Minneapolis, Minnesota

  • University of Minnesota

    Minneapolis, Minnesota

  • Mayo Clinic Rochester

    Rochester, Minnesota

  • Washington University in St Louis

    St Louis, Missouri

  • Comprehensive Cancer Centers of Nevada

    Las Vegas, Nevada

  • University of New Mexico Cancer Center

    Albuquerque, New Mexico

  • Columbia University Medical Center

    New York, New York

  • Memorial Sloan Kettering Cancer Center

    New York, New York

  • Weill Cornell Medicine

    New York, New York

  • Wake Forest Baptist Medical Center / Wake Forest University

    Winston-Salem, North Carolina

  • Case Western Reserve University / University Hospitals Cleveland Medical Center

    Cleveland, Ohio

  • The Cleveland Clinic

    Cleveland, Ohio

  • Oregon Health and Science University

    Portland, Oregon

  • Tennessee Oncology-Nashville/Sarah Cannon Research Institute

    Nashville, Tennessee

  • Texas Oncology - Baylor Sammons Cancer Center

    Dallas, Texas

  • Cancer Care Centers of South Texas - HOAST/Texas Oncology

    New Braunfels, Texas

  • Northwest Medical Specialties

    Puyallup, Washington

  • Swedish Cancer Institute

    Seattle, Washington

  • Seattle Cancer Care Alliance / University of Washington

    Seattle, Washington

  • West Virginia University

    Morgantown, West Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.